“When people are confused or overwhelmed with information, it can...
Category:
Health
Latest
Lack of sleep reduces cognitive benefits of physical activity: Lancet Study
Ppeople who were more physically active but had short sleeps - less...
Global diet study challenges advice to limit high-fat dairy foods
''Our findings suggest that the priority should be increasing...
Experimental drug can speed up Covid-19 recovery, says new study
“This treatment has large therapeutic potential, especially at this moment as we see aggressive variants of the virus spreading around the globe which are less sensitive to both vaccines and treatment with antibodies,” said study co-author Jordan Feld from the Toronto Centre for Liver Disease in Canada.
Did Covid-19 come from Wuhan seafood market? Investigators find fresh clues
Investigators want to know how the SARS-CoV-2 virus — whose closest known relative came from bats 1,000 miles away — spread explosively in Wuhan before causing the worst contagion in more than a century. Daszak said the investigation heralds a turning point in pandemic mitigation.
Indian economy is witnessing V-shaped recovery, says Anurag Thakur
“In the next four to five years, India would become a USD five trillion economy. The general budget for 2021-22 has been designed carefully,” he said.
Is it safe to take painkillers before or after getting vaccinated for coronavirus?
Certain painkillers that target inflammation, including ibuprofen (Advil, Motrin and other brands) might curb the immune response. A study on mice in the Journal of Virology found these drugs might lower production of antibodies – helpful substances that block the virus from infecting cells.
If you’re already taking one of those medications for a health condition, you should not stop before you get the vaccine – at least not without asking your doctor, said Jonathan Watanabe, a pharmacist at the University of California, Irvine.
India developing 7 more COVID vaccines,Vax for 50+ group from March: Harsh Vardhan
He said the Centre does not have any immediate plan to make the vaccines available in the open market and a decision will be taken as the situation demands.
The COVID-9 inoculation process for people aged above 50 will start in March, he told reporters.
UK begins world-first alternate dosing Covid-19 vaccine trial
The study, backed by 7 million pound of government funding, will determine the effects of using different vaccines for the first and second dose – for example, using Oxford University/AstraZeneca’s vaccine for the first dose, followed by Pfizer/BioNTech’s vaccine for the second.
Over 12,000 COVID-19 cases reported in one day, 78 new fatalities recorded
The number of people who have recuperated from the disease surged to 1,05,22,601 pushing the national COVID-19 recovery rate of 97.20 per cent, while the case fatality rate stands at 1.43 per cent.
There are 1,48,766 active coronavirus infections in the country which comprises 1.37 per cent of the total caseload, the data stated.
Higher deficit shouldn’t put pressure on India’s sovereign rating: DEA Secy
As per the latest Budget numbers, India’s fiscal deficit is estimated to be 9.5 per cent of the GDP in the current fiscal and is expected to come down to 6.8 per cent in 2021-22 beginning April 1.
Global rating agencies have the lowest investment-grade rating on India, which is just above the junk status.
Nurses, female health care workers most at risk of distress during COVID-19 pandemic: Research
“By analysing data from previous infectious disease outbreaks such as SARS, bird flu and swine flu, it appears that distress for health care workers can persist for up to three years after the initial outbreak.
“As the world continues to tackle the COVID-19 pandemic it is so important that we identify the health care workers who are most at risk for distress and the factors that can be modified to reduce distress and improve resilience,” Dr Fuschia Sirois, Reader in Social and Health Psychology in the university and lead author of the study said.
Oxford kept Covid-19 vaccine trial volunteers in dark about dosing error, letter shows
Questions surrounding the clinical trials continue to plague the vaccine. Last week, Germany’s vaccine committee recommended it should only be given to people aged under 65, while the EU, which authorized it on Friday for people aged 18 and over, lowered its reported efficacy rate from 70.4% to 60%. In both cases, authorities cited a lack of sufficient data from the clinical trials.